{
  "name" : "_cyber.sci-hub.se_MTAuMTAxNi9qLnRhYXAuMjAxNS4xMS4wMDg=_westmeier2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM)",
    "authors" : [ "Dana Westmeier", "Roland H. Stauber", "Dominic Docter" ],
    "emails" : [ "docter@uni-mainz.de" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Toxicology and Applied Pharmacology xxx (2015) xxx–xxx\nYTAAP-13519; No of Pages 5\nContents lists available at ScienceDirect\nToxicology and Applied Pharmacology\nj ourna l homepage: www.e lsev ie r .com/ locate /ytaap\nThe concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM)\nDana Westmeier, Roland H. Stauber, Dominic Docter ⁎ Department of Nanobiomedicine/ENT, University Medical Center of Mainz, Langenbeckstr. 1, 55101 Mainz, Germany\n⁎ Corresponding author. E-mail address: docter@uni-mainz.de (D. Docter).\nhttp://dx.doi.org/10.1016/j.taap.2015.11.008 0041-008X/© 2015 Elsevier Inc. All rights reserved.\nPlease cite this article as:Westmeier, D., et al Appl. Pharmacol. (2015), http://dx.doi.org/1\na b s t r a c t a r t i c l e i n f o\nArticle history: Received 11 September 2015 Revised 5 November 2015 Accepted 16 November 2015 Available online xxxx\nBesides thewide use of engineerednanomaterials (ENM) in technical products, their application spectrum inbiotechnology and biomedicine is steadily increasing. In complex physiological environments the physico-chemical properties and the behavior of nanoparticles (NPs) are challenging to characterize. Biomolecules rapidly adsorb to the nanomaterial, leading to the formation of the protein/biomolecule corona, which critically affects the nanomaterials' (patho)biological and technical identities. This formation can trigger an immune response and affect nanoparticles' toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the (protein)corona-nanoparticle interaction and discuss how the corona modulates both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers.\n© 2015 Elsevier Inc. All rights reserved. Keywords: Corona Nanotoxicology Nanomedicine"
    }, {
      "heading" : "1. Introduction",
      "text" : "Since 2004 “nanotoxicology” has emerged an autonomous fieldwith an explosive growth. As illustrated in Fig. 1, querying the PubMed database with the search term ‘nanotoxicology’ reveals that more than 238 reports have been published on this topic by September 2015 (in 2004 only two reports were found). Such developments are influenced by the increasing exposure of humans and the environment to nanomaterials (NM). The ability to create nanomaterial in a wide variety of different combinations concerning their chemistry, shape, size and surface properties led to the concentration of the nanotoxicological aspects regarding these NM characteristics. Although, due to their high surface energy, NMs adsorb (bio)molecules upon contact with any kind of biological environment, consequently forming the so-called (bio)molecule corona, the role of this corona in toxicological aspects has been completely neglected so far (Docter et al., 2015a; Nel et al., 2009). As the topic of this mini-review is about the “the concept of the biocorona”, we again inquired the PubMed database with the search terms ‘nanotoxicology’ AND ‘corona’. From 2004 to 2007 we found zero reports and by September 2015 only 14 studies were published on this topic (Fig. 1). In this mini-review we will introduce you to the history and the importance of the biomolecule corona, on its impact on biomedical applications as well as its influence on the still young field of nanotoxicology.\n., The concept of bio-corona in 0.1016/j.taap.2015.11.008"
    }, {
      "heading" : "2. The corona concept",
      "text" : "The applications of engineered nanomaterials (ENMs) are not only increasing in technical products but also more and more in biotechnology and biomedicine (Docter et al., 2015a; Reese, 2013; Webster, 2013; Docter et al., 2015b; Setyawati et al., 2015). Thus, the ‘marriage’ of nanotechnology with biomedicine defines one of the most exciting and cross-disciplinary developments over the last decade (Reese, 2013; Webster, 2013). Nanomedicine is the field of science devoted to the medical application of ENMs. Recent years have been a surge in the development of nanomaterials as therapeutic and diagnostic agents, paralleled by major advances in the development of nano-sized delivery systems for targeted drug administration. The manipulation of ENMs' physico-chemical features opens up new horizons to rationally design a variety of clinically relevant applications like drug delivery, in vitro diagnostics, imaging nanoprobes, contrast agents and photodynamic therapy agents (Qian et al., 2008; Helou et al., 2013). Moreover, with the advent of the concept of so called ‘personalized medicine’, the field has started to grow producing a huge variety of different (multi-) functional ENMs (Muthu et al., 2014). Such developments will also lead to an increasing exposure of humans and the environment to ENMs. In this scenario, it is important to understand the interactions occurring at the interface between ENMs and biological components in order to predict the fate of (injected) ENMs. Due to their high surface energy, ENMs adsorb (bio)molecules upon contact with biological and/or abiotic environments, forming the so-called (bio)molecule corona (latin for crown) around them, transforming the bare ENM into a ENM with a biological coating (Docter et al., 2015a; Cedervall et al., 2007; Tenzer et al., 2013; Monopoli et al., 2012;\nmodulating the toxicity of engineered nanomaterials (ENM), Toxicol.\nFig. 1. Timeline of PubMed entries matching the search criteria ‘nanotoxicology’ and the subgroup ‘nanotoxicology and corona’. Querying PubMed by using the search criteria ‘nanotoxicology’ reveals a constantly growing number of publications over the last ten years whereas the subgroup within this search based on the criteria ‘nanotoxicology and corona’ is still in its infancy. Albeit, the trend indicates that the ‘corona’ concerning ‘nanotoxicology’ represents an unresolved hot topic with high scientific relevance.\nMonopoli et al., 2011). Thus, whereas the physico-chemical properties and behavior of ENMs can be engineered and controlled in technically stable, protected environments, such as technical products, this is no longer the case in complex physiological or natural environments.\nAlthough protein adsorption onto surfaces has been known for a long time since the pioneering work by Vroman (1962), where he postulated the ‘Vroman effect’, a continuous flux of desorption/adsorption of proteins. This means that at any time an initially attached protein can desorb from an ENM and can be replaced by a different one with larger affinity. Thereby the protein corona composition is substantially changed, while the amount of adsorbed proteins remains at a relatively constant level. In theory, proteins, that are more abundant in the biological fluids, are the first to be adsorbed during the initial phase. Then, they are replaced by proteins of lower abundance but higher affinity, which remain around the ENM for longer times (Nel et al., 2009; Cedervall et al., 2007). The term ‘protein corona’was introduced to the nanoparticle community much later in the study of Cedervall et al. (2007). Hereby, awhole field of new investigations was stimulated. Although, somehow loosely defined, the term ‘hard protein corona’ was coined as the (first) tightly bound layer of biomoleculeswith a long exchange timewhich represents an analytically accessible protein/biomolecule signature of an ENM in the respective environment (Docter et al., 2015b; Tenzer et al., 2013; Monopoli et al., 2012). In addition, some models further suggest that on top of this ‘hard corona’, a ‘soft protein corona’ exists, consisting of loosely associated and rapidly exchanging highly complex layers of biomolecules, not directly connected to the ENM (Monopoli et al., 2012; Walczyk et al., 2010; Walkey et al., 2014). However, since this ‘soft corona’ desorbs during current purification processes, its existence, analytical dissection and, particularly, its relevance for effects at the nano–bio interface remain to be fully confirmed. Therefore, as inspection of the current literature revealed that the term ‘soft’ versus ‘hard’ corona seems to mostly createmore confusion than helping to describe and resolve scientific questions, we mean the hard protein corona, when referring to the protein corona. As the hard protein corona represents the effective biological identity of the ENM (Fig. 2), we will use this term throughout the review.\nTypically, corona profiles differ significantly from the protein composition of the (biological) fluid investigated (Tenzer et al., 2013; Monopoli et al., 2012; Walkey et al., 2014; Tenzer et al., 2011). For example, although blood plasma is constituted by thousands of proteins and some of them are more abundant than others, they are not necessarily present in the protein corona of ENMs or, at least they are not necessarily themore abundant ones (Tenzer et al., 2011; Zhang et al., 2011; Martel et al., 2011). Distinct proteins will be either enriched or will display only a weak affinity for the nanoparticle surface. Furthermore, not\nPlease cite this article as:Westmeier, D., et al., The concept of bio-corona in Appl. Pharmacol. (2015), http://dx.doi.org/10.1016/j.taap.2015.11.008\nonly the particle material, size and the surface properties have been shown to play a role in determining the composition of the protein corona, also exposure time and the relative ratio of the physiological fluid (e.g. human ormurine, plasma or serum) to the nanoparticle dispersion are critical aspects (Docter et al., 2015b; Walkey and Chan, 2012). But none of the above-mentioned factors alone is able to be used to determine the formation and composition of the biomolecule corona. The relation between the pristine ENM characteristics and the nature of the corona is far from trivial, and currently still remains impossible to predict in complex physiological environments. The scientific community is now moving from the mere evaluation of the impact of the biomolecule corona on the physical and chemical properties of ENMs to the physiological impact of the ENMs."
    }, {
      "heading" : "3. Targeting the capability of nanoparticles in the light of the biomolecule corona",
      "text" : "Over the past decades nanocarriers were designed in the attempt to: i) increase drug bioavailability and avoid drug inactivation, which is particularly important in the case of poorly soluble compounds, or degradation by blood proteases/peptidases or nucleases (Riehemann et al., 2009); ii) minimize side effects due to a non-specific body distribution of the drug and to the high amount of drug commonly used (Ferrari, 2005), and iii) selectively deliver the payload to the affected area, thereby increasing its tissue accumulation (Bertrand et al., 2014). While the first-generation nanocarriers, such as micelles, PEGylated liposomes, and polymeric NPs, fully address the first two points by increasing the pharmacokinetics and tolerability of nano-formulate drugs (Riehemann et al., 2009; Dobrovolskaia and McNeil, 2015), the second-generation nanocarriers take advantages from active targeting strategies to tissue-specific delivery (Yang et al., 2012; Meng et al., 2013). As several receptors on the cell surface are over-expressed in diseases such as cancer (Danhier et al., 2010), these approaches are based on the functionalization of the carrier surface with active molecules,\nmodulating the toxicity of engineered nanomaterials (ENM), Toxicol.\ne.g. ligands for cell membrane receptors and monoclonal antibodies (Torchilin, 2014).\nAs described above, the biomolecule corona strongly affects the fate and biological impact of ENMs, as well as their therapeutic and pathophysiological effects. Since the biomolecule corona coats the ENM surface and, as a consequence, the chemical modification with which they are functionalized, it is important to understand the impact of the biomolecule corona on the targeting properties of ENMs. As shown by Salvati et al., the targeting properties of such ENMs may disappear when they are placed in a biological environment (Salvati et al., 2013). Even by conjugating transferrin onto nanoparticles, and thus producing an artificial corona consisting of one biomolecule, the authors found that proteins in the media are still able to bind to the nanoparticles and hereby shield transferrin from binding to both its targeted receptors on cells and soluble transferrin receptors. Although, nanoparticles continue to enter cells, the targeting specificity of transferrin was lost (Salvati et al., 2013). These findings illustrate the importance of studying the physico-chemical properties of ENMs in the experimental conditions in which they will be applied and to additionally exploit the ENMs' biological identity by determining the biomolecule corona. The nanomedicine field has reached an important stage by now accepting that the biomolecule corona does exist for themajority of nanomaterials used in biomedicine, seems to be established rapidly and is highly complex in most if not all physiological relevant environments."
    }, {
      "heading" : "4. Application routes and biodistribution of nanoparticles",
      "text" : "Upon administration NPs will interact with cells. It is well accepted from cell-culture studies that almost all mammalian cells are, in principle, capable to incorporate NPs to some extent, due to a variety of unspecific uptake mechanisms (Hillaireu and Couvreur, 2009). Many studies have explored the NP properties which influence efficiency of cellular uptake and determine also their intracellular processing resulting in complete or partly degradation, or storage of NPs in unchanged form in the cell (Nazarenus et al., 2014). However, how relevant is this for the in vivo situation? In vivo, a close interaction between tissues exists, in which certain cell types such as the professional macrophages in the monocyte-macrophage system (MMS) are very potent in a fast clearance and processing of larger NPs from the blood flow, whereas other cells may be very limited in their capacity to process NPs. Besides the physico-chemical properties of the individual NPs, the cell types exposed to the NPs will also influence the biodistribution and degradation of NPs in vivo. For amany nanomedical application, i.e. intended NP administration, a bolus injection into a peripheral vein (intravenous, i.v.) seems to be the most suitable application route. Likewise, also the pulmonal (Lipka et al., 2010), dermal (Lademann et al., 2011; Vogt et al., 2014; Nohynek et al., 2007) and oral uptake routes (Schleh et al., 2012) (Fig. 3) have to be taken into account, in particular also for unintended NP exposure via air pollution or spills. However, very little quantitative information is so far available, how efficient these uptake processes are in vivo. It should be emphasized that we know too little about the detailed distribution of a given NP composites in vivo and that reliable techniques are urgently needed to document which cells do take up the respective NPs to what extent. After intravenous injection, most NPs tend to be cleared from the blood by the reticuloendothelial system of the liver and spleen without degradation or excretion (Fabian et al., 2008). The liver and kidneys are the major organs responsible for NP excretion (Li et al., 2010) through bile and urine, respectively (Souris et al., 2010)."
    }, {
      "heading" : "5. Toxicological implication of the protein corona",
      "text" : "The formation of a protein corona impacts not only on the delivery properties of NPs (e.g. biodistribution and clearance), it can also influence their toxicity and pathophysiology (Tenzer et al., 2013). Studies\nPlease cite this article as:Westmeier, D., et al., The concept of bio-corona in Appl. Pharmacol. (2015), http://dx.doi.org/10.1016/j.taap.2015.11.008\non the specific role of the biomolecule corona in favoring toxicity have produced contrasting results. For example, in the study by Tenzer et al., the authors showed the (patho)biological relevance of the protein corona in in vitro studies of primary human cellmodels of the blood system. Pristine nanoparticles existed only for a short period of time, but could immediately affect vitality of endothelial cells, trigger thrombocyte activation and aggregation, and result in hemolysis. Formation of the biomolecule corona rapidly modulated the nanoparticles' decoration with bioactive proteins, thus, protecting cells of the blood system against nanoparticle induced (patho)biological processes, and could also promote cellular uptake (Tenzer et al., 2013). Also in the study by Wang et al., only the uncoated silica particles had a significant hemolytic effect on red blood cells whereas the formation of a biomolecule corona on theparticle surface protected the cells from this damage (Wang et al., 2013). The protection afforded by the protein coating is better appreciated when the particles are positively charged, since this physical feature was shown to trigger cell death via apoptosis (Wang et al., 2013).\nThe protein corona plays a critical role in cellular uptake (Pelaz et al., 2015), accumulation, biodegradation and clearance of NPs (Saptarshi et al., 2013). It is becoming clear that the protein corona has also the ability tomediate or to alter immune responses. However, investigators\nmodulating the toxicity of engineered nanomaterials (ENM), Toxicol.\nare cautious and tend to refute the notion of differential immune stimuli dependence on the nanoparticle protein corona-complex. The immune system is expected to react to NPs, and thus, a better understanding of nano-immuno interactions is critical for the safe application of engineered NPs in medicine (Farrera and Fadeel, 2015). Especially, injected NPs could be considered as one of the potential body invaders. For example Yan et al. showed the selective cell recognition for protein corona formation on poly-(methacrylic acid) nanoporous polymer particles (Yan et al., 2013). Compared to the uptake of bare NPs, THP-1 (human monocytic cell line) internalized much fewer NPs in the presence of serum albumin. On the contrary, in the case of macrophagelike cells, differentiated THP-1, the presence of albumin on the NP surface induced an increase in the internalization rate accompanied by secretion of inflammatory cytokines as proof of the activated phagocytosis (Yan et al., 2013; Lee et al., 2015).\nPlain inorganic nanoparticles, like quantumdots, are not stable in biological environments.Without organic surface coating, either obtained by chemical design or due to adsorbed proteins, the NPs agglomerate. Thus, these ENM in in vivo environment are complex hybrids with an inorganic core and an organic/biologic surface (biomolecule corona) coating (Rivera-Gil et al., 2013). The NP core defines the “physical identity” of the NPs and the engineered surface coating determines the intrinsic physico-chemical properties of the NPs, sometimes termed “synthetic identity”. Cytotoxic effects of the ENM can potentially arise from the core and/or from the surface coating (Rivera-Gil et al., 2013). For example, using identical CdSe cores, the toxicity of CdSe ENM is strongly influenced by their surface chemistry (Kirchner et al., 2005). Whereas experiments with ENM with different cores (Au, FePt, no core) but the same surface coating gave an example in which the core (Au, FePt), but not the surface coating alone (i.e., polymermicelleswithout inorganic core inside), was responsible for cytotoxic effects (Lehmann et al., 2010). Thus, for any cytotoxicity study the hybrid nature of ENM, i.e. the inorganic core, organic surface and the biomolecule corona must be taken into account.\nOne of the major goals in nanomedicine is to prolong the circulation time of NPs by preventing the non-specific uptake by cells of the reticuloendothelial system (RES). In this context, grafting of hydrophilic polymers,which sterically stabilize nanoparticles, can reduce the adsorption of the proteins onto the surface. Currently, the most established hydrophilic polymer for surface modification of nanoparticles is polyethylene glycol (PEG) (Pelaz et al., 2015; Nakamura et al., 2015). However, despite of all the advantages of PEG, several factors can hinder the application of PEGylated drug carriers, for example the formation of toxic peroxides as a degradation product of PEG or the accumulation of PEG in organs by vacuolization (Zhang et al., 2014; Xu et al., 2013). As a consequence of these drawbacks, there is a need for an alternative to PEG for the surface modifications, which may be found in poly(2-alkyl-2oxazolines) (POX), a promisingpolymerwith impact on protein adsorption and on non-specific clearance of the NPs comparable to PEG but without the described drawbacks. However, its potential has yet to be confirmed (Sedlacek et al., 2012; Shah et al., 2015; Zhao et al., 2015).\nBiomimetic drug delivery carriers, inspired from abundant preexisting biosources, have great potential for providing safe, biocompatible, and readily applicable delivery vehicles (Yoo et al., 2011). Here, natural occurring NPs can serve as an excellent role-model to design safe and efficient nanocarriers. In nature, the low-density lipoproteins (LDL) present another promising template for designing nano-delivery systems (Ng et al., 2011) consisting of an apolar core surrounded by its own “lipoprotein corona” of phospholipids that may be modified for a targeting and delivering role in nanomedical approaches (Wu et al., 2009). These LDLs with their own core-shell structure essentially function as 20 nm-sized natural-source nanoparticles that circulate in the human body and transport cholesterols between peripheral tissues. Thus, novel solid lipid nanoparticle based systems designed to mimic the composition of LDLs could provide a biocompatible nanoparticulate drug delivery system (Huang\nPlease cite this article as:Westmeier, D., et al., The concept of bio-corona in Appl. Pharmacol. (2015), http://dx.doi.org/10.1016/j.taap.2015.11.008\net al., 2015) and were already described as an efficient delivery carrier of nucleic acids (Kim et al., 2008)."
    }, {
      "heading" : "6. Conclusion",
      "text" : "Amajor challenge in nanomedicine is to engineerNPswhich are able to overcome the biological barriers that separate them from the target cells. To reach its target, synthetic NPs get into contact with a biological environment that confers part of its ‘bio’ nature on them, thereby endowing them with a bio-identity. The ability to (fine-)tune the protein corona composition itself could potentially enable new possibilities in overcoming biological barriers, such as the blood–brain-barrier, help to mitigate toxicity, improve uptake, and direct bioavailability and clearance. Despite the fact that the relationship between nanomaterial design and the physiological response has been studied intensely for more than two decades, only some general principles have emerged. (i) Changes in colloidal stability are expected to occur most likely in the ambient ion concentrations in biological fluids, which turn the determination of critical NP parameters still into a challenging task. Nevertheless, the nanomedicine field has reached an important stage by now accepting that the highly complex protein corona does exist for the majority of nanomaterials used in biomedicine and establishes rapidly in most if not all physiological relevant environments. Many different studies showed that a ‘typical’ plasma protein corona consists of more than hundred (if not several hundreds) different proteins adsorbed at abundance, and is potentially capable of modulating biological responses. (ii) Also the long term existence of pristine NPs in complex physiological environments appears to be rather an exception to the rule, so we have understood that when a cell or an organ is presented with an NP, it does not primarily see the bare particle. (iii) There is still an unresolved debate about whether corona profiles change significantly over time, particularly in time frames in which biological responses are expected. Nevertheless, the long-term effects and the relevance of coronas on the fate and transformation of NPs deposited in organs require future attention. (iv) Moving forward clearly requires standard operating procedures (SOPs), detailed enough to ensure data quality and allow inter-laboratory comparison. Quantitative, highresolution label-free quantitative liquid chromatography mass spectrometry (LC-MS) is now capable of dramatically reducing the biomolecule corona characterization time and can provide quantitative data from large libraries of nanomaterials. (v) Furthermore, novel bioinformatic algorithms are under development for in silicomodeling and prediction. Establishing nanostructure activity-relationships linking NP/ corona properties to (patho)physiological responses remain a still distant goal despite the achievements of the past years. Such knowledge is ultimately needed not only to understand and minimize nanotoxicity but also to develop NPs for improved future nanomedical applications. (vi) Nanomedicine has so farmainly relied on the knowledge of sophisticated nanomaterial synthesis and engineering. It is mandatory to now join forces and to additionally exploit the NPs' biological identity, which is substantially determined by the biomolecule corona (consisting not only of proteins but also lipids and sugars). Once fully mapped, the relationships between synthetic versus biological identity and the resulting physiological response will ultimately aid the innovation of novel more effective therapies and biological applications of engineered nanomaterials. Although, one should not neglect natural occurringmolecules, e.g. viruses or low-density lipoproteins, that are already out there to serve as a template for the development of a safe and efficient nano-delivery-system.\nTransparency Document\nThe Transparency Document associated with this article can be found, in online version.\nmodulating the toxicity of engineered nanomaterials (ENM), Toxicol."
    }, {
      "heading" : "Acknowledgments",
      "text" : "Grant support: BMBF-MRCyte (13N1202)/NanoBEL (03XP0003H)/ DENANA (03X0152H), Zeiss-ChemBioMed (0563-2.8/399/1), Stiftung Rheinland-Pfalz (NanoScreen), DFGSPP1313, PTE-foundation and Fonds der chemischen Industrie. We apologize to all colleagues whose work could not be cited due to space limitations.We thank Dr. Christian Eufinger and the PhD L&L group for helpful discussion."
    } ],
    "references" : [ {
      "title" : "Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer",
      "author" : [ "N Bertrand" ],
      "venue" : "biology. Adv. Drug Deliv. Rev",
      "citeRegEx" : "Bertrand,? \\Q2014\\E",
      "shortCiteRegEx" : "Bertrand",
      "year" : 2014
    }, {
      "title" : "Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles",
      "author" : [ "T Cedervall" ],
      "venue" : "Proc. Natl. Acad. Sci. U. S. A",
      "citeRegEx" : "Cedervall,? \\Q2007\\E",
      "shortCiteRegEx" : "Cedervall",
      "year" : 2007
    }, {
      "title" : "To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery",
      "author" : [ "F. Danhier", "O. Feron", "V. Preat" ],
      "venue" : "J. Control. Release",
      "citeRegEx" : "Danhier et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Danhier et al\\.",
      "year" : 2010
    }, {
      "title" : "Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics",
      "author" : [ "M.A. Dobrovolskaia", "S.E. McNeil" ],
      "venue" : "Expert Opin. Drug Deliv",
      "citeRegEx" : "Dobrovolskaia and McNeil,? \\Q2015\\E",
      "shortCiteRegEx" : "Dobrovolskaia and McNeil",
      "year" : 2015
    }, {
      "title" : "The nanoparticle biomolecule corona: lessons learned — challenge accepted",
      "author" : [ "D Docter" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "Docter,? \\Q2015\\E",
      "shortCiteRegEx" : "Docter",
      "year" : 2015
    }, {
      "title" : "2015b. No king without a crown — impact of the nanomaterial-protein corona on nanobiomedicine",
      "author" : [ "D Docter" ],
      "venue" : "Nanomedicine (Lond)",
      "citeRegEx" : "Docter,? \\Q2015\\E",
      "shortCiteRegEx" : "Docter",
      "year" : 2015
    }, {
      "title" : "Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats",
      "author" : [ "E Fabian" ],
      "venue" : "Arch. Toxicol",
      "citeRegEx" : "Fabian,? \\Q2008\\E",
      "shortCiteRegEx" : "Fabian",
      "year" : 2008
    }, {
      "title" : "It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system",
      "author" : [ "C. Farrera", "B. Fadeel" ],
      "venue" : "Eur. J. Pharm. Biopharm",
      "citeRegEx" : "Farrera and Fadeel,? \\Q2015\\E",
      "shortCiteRegEx" : "Farrera and Fadeel",
      "year" : 2015
    }, {
      "title" : "Cancer nanotechnology: opportunities and challenges",
      "author" : [ "M. Ferrari" ],
      "venue" : "Nat. Rev. Cancer",
      "citeRegEx" : "Ferrari,? \\Q2005\\E",
      "shortCiteRegEx" : "Ferrari",
      "year" : 2005
    }, {
      "title" : "Time-of-flight magnetic flow cytometry in whole blood with integrated sample preparation",
      "author" : [ "M Helou" ],
      "venue" : "Lab Chip",
      "citeRegEx" : "Helou,? \\Q2013\\E",
      "shortCiteRegEx" : "Helou",
      "year" : 2013
    }, {
      "title" : "Nanocarriersメ entry into the cell: relevance to drug",
      "author" : [ "H. Hillaireu", "P. Couvreur" ],
      "venue" : "delivery. Cell. Mol. Life Sci",
      "citeRegEx" : "Hillaireu and Couvreur,? \\Q2009\\E",
      "shortCiteRegEx" : "Hillaireu and Couvreur",
      "year" : 2009
    }, {
      "title" : "Learning from biology: synthetic lipoproteins for drug",
      "author" : [ "H Huang" ],
      "venue" : "delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol",
      "citeRegEx" : "Huang,? \\Q2015\\E",
      "shortCiteRegEx" : "Huang",
      "year" : 2015
    }, {
      "title" : "Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA",
      "author" : [ "Kim", "H.R" ],
      "venue" : "Mol. Pharm",
      "citeRegEx" : "Kim and H.R,? \\Q2008\\E",
      "shortCiteRegEx" : "Kim and H.R",
      "year" : 2008
    }, {
      "title" : "Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles",
      "author" : [ "C Kirchner" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "Kirchner,? \\Q2005\\E",
      "shortCiteRegEx" : "Kirchner",
      "year" : 2005
    }, {
      "title" : "Stimulation of the penetration of particles into the skin by plasma tissue interaction",
      "author" : [ "O Lademann" ],
      "venue" : "Laser Phys. Lett",
      "citeRegEx" : "Lademann,? \\Q2011\\E",
      "shortCiteRegEx" : "Lademann",
      "year" : 2011
    }, {
      "title" : "Effect of the protein corona on nanoparticles formodulating cytotoxicity and immunotoxicity",
      "author" : [ "Lee", "Y.K" ],
      "venue" : "Int. J. Nanomedicine",
      "citeRegEx" : "Lee and Y.K,? \\Q2015\\E",
      "shortCiteRegEx" : "Lee and Y.K",
      "year" : 2015
    }, {
      "title" : "Fluorescent-magnetic hybrid nanoparticles induce a dosedependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization",
      "author" : [ "Lehmann", "A.D" ],
      "venue" : "Small 6",
      "citeRegEx" : "Lehmann and A.D,? \\Q2010\\E",
      "shortCiteRegEx" : "Lehmann and A.D",
      "year" : 2010
    }, {
      "title" : "Physiologically based pharmacokinetic modeling of nanoparticles",
      "author" : [ "M Li" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Li,? \\Q2010\\E",
      "shortCiteRegEx" : "Li",
      "year" : 2010
    }, {
      "title" : "Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection",
      "author" : [ "M Lipka" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "Lipka,? \\Q2010\\E",
      "shortCiteRegEx" : "Lipka",
      "year" : 2010
    }, {
      "title" : "Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandemmass spectrometry",
      "author" : [ "J Martel" ],
      "venue" : "Anal. Biochem",
      "citeRegEx" : "Martel,? \\Q2011\\E",
      "shortCiteRegEx" : "Martel",
      "year" : 2011
    }, {
      "title" : "Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo",
      "author" : [ "H Meng" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Meng,? \\Q2013\\E",
      "shortCiteRegEx" : "Meng",
      "year" : 2013
    }, {
      "title" : "Nanobiotechnology: nanoparticle coronas take shape",
      "author" : [ "M.P. Monopoli", "F.B. Bombelli", "K.A. Dawson" ],
      "venue" : "Nat. Nanotechnol",
      "citeRegEx" : "Monopoli et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Monopoli et al\\.",
      "year" : 2011
    }, {
      "title" : "Biomolecular coronas provide the biological identity of nanosized materials",
      "author" : [ "Monopoli", "M.P" ],
      "venue" : "Nat. Nanotechnol",
      "citeRegEx" : "Monopoli and M.P,? \\Q2012\\E",
      "shortCiteRegEx" : "Monopoli and M.P",
      "year" : 2012
    }, {
      "title" : "Nanotheranostics — application and further development of nanomedicine strategies for advanced theranostics",
      "author" : [ "Muthu", "M.S" ],
      "venue" : "Theranostics",
      "citeRegEx" : "Muthu and M.S,? \\Q2014\\E",
      "shortCiteRegEx" : "Muthu and M.S",
      "year" : 2014
    }, {
      "title" : "Identification of polyethylene glycol-resistant macrophages on stealth imaging in vitro using fluorescent organosilica nanoparticles",
      "author" : [ "M Nakamura" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Nakamura,? \\Q2015\\E",
      "shortCiteRegEx" : "Nakamura",
      "year" : 2015
    }, {
      "title" : "In vitro interaction of colloidal nanoparticles with mammalian cells: what have we learned thus far",
      "author" : [ "M Nazarenus" ],
      "venue" : "Beilstein J. Nanotechnol",
      "citeRegEx" : "Nazarenus,? \\Q2014\\E",
      "shortCiteRegEx" : "Nazarenus",
      "year" : 2014
    }, {
      "title" : "Understanding biophysicochemical interactions at the nano-bio interface",
      "author" : [ "Nel", "A.E" ],
      "venue" : "Nat. Mater",
      "citeRegEx" : "Nel and A.E,? \\Q2009\\E",
      "shortCiteRegEx" : "Nel and A.E",
      "year" : 2009
    }, {
      "title" : "Lipoprotein-inspired nanoparticles for cancer theranostics",
      "author" : [ "K.K. Ng", "J.F. Lovell", "G. Zheng" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "Ng et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Ng et al\\.",
      "year" : 2011
    }, {
      "title" : "Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety",
      "author" : [ "Nohynek", "G.J" ],
      "venue" : "Crit. Rev. Toxicol",
      "citeRegEx" : "Nohynek and G.J,? \\Q2007\\E",
      "shortCiteRegEx" : "Nohynek and G.J",
      "year" : 2007
    }, {
      "title" : "Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake",
      "author" : [ "B Pelaz" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Pelaz,? \\Q2015\\E",
      "shortCiteRegEx" : "Pelaz",
      "year" : 2015
    }, {
      "title" : "In vivo tumor targeting and spectroscopic detection with surfaceenhanced Raman nanoparticle",
      "author" : [ "X Qian" ],
      "venue" : "tags. Nat. Biotechnol",
      "citeRegEx" : "Qian,? \\Q2008\\E",
      "shortCiteRegEx" : "Qian",
      "year" : 2008
    }, {
      "title" : "Nanotechnology: using co-regulation to bring regulation of modern technologies into the 21st century",
      "author" : [ "M. Reese" ],
      "venue" : "Health matrix",
      "citeRegEx" : "Reese,? \\Q2013\\E",
      "shortCiteRegEx" : "Reese",
      "year" : 2013
    }, {
      "title" : "Nanomedicine—challenge and perspectives",
      "author" : [ "K Riehemann" ],
      "venue" : "Angew. Chem. Int. Ed. Engl",
      "citeRegEx" : "Riehemann,? \\Q2009\\E",
      "shortCiteRegEx" : "Riehemann",
      "year" : 2009
    }, {
      "title" : "The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity",
      "author" : [ "P Rivera-Gil" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "Rivera.Gil,? \\Q2013\\E",
      "shortCiteRegEx" : "Rivera.Gil",
      "year" : 2013
    }, {
      "title" : "Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface",
      "author" : [ "A Salvati" ],
      "venue" : "Nat. Nanotechnol",
      "citeRegEx" : "Salvati,? \\Q2013\\E",
      "shortCiteRegEx" : "Salvati",
      "year" : 2013
    }, {
      "title" : "Interaction of nanoparticleswith proteins: relation to bio-reactivity of the nanoparticle",
      "author" : [ "S.R. Saptarshi", "A. Duschl", "A.L. Lopata" ],
      "venue" : "J. Nanobiotechnol",
      "citeRegEx" : "Saptarshi et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Saptarshi et al\\.",
      "year" : 2013
    }, {
      "title" : "Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration",
      "author" : [ "C Schleh" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "Schleh,? \\Q2012\\E",
      "shortCiteRegEx" : "Schleh",
      "year" : 2012
    }, {
      "title" : "Poly(2-oxazoline)s — are they more advantageous for biomedical applications than other polymers? Macromol",
      "author" : [ "O Sedlacek" ],
      "venue" : "Rapid Commun",
      "citeRegEx" : "Sedlacek,? \\Q2012\\E",
      "shortCiteRegEx" : "Sedlacek",
      "year" : 2012
    }, {
      "title" : "Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood",
      "author" : [ "Setyawati", "M.I" ],
      "venue" : null,
      "citeRegEx" : "Setyawati and M.I,? \\Q2015\\E",
      "shortCiteRegEx" : "Setyawati and M.I",
      "year" : 2015
    }, {
      "title" : "In vitro study of partially hydrolyzed poly(2-ethyl-2-oxazolines) as materials for biomedical applications",
      "author" : [ "R Shah" ],
      "venue" : "J. Mater. Sci. Mater. Med",
      "citeRegEx" : "Shah,? \\Q2015\\E",
      "shortCiteRegEx" : "Shah",
      "year" : 2015
    }, {
      "title" : "Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles",
      "author" : [ "Souris", "J.S" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "Souris and J.S,? \\Q2010\\E",
      "shortCiteRegEx" : "Souris and J.S",
      "year" : 2010
    }, {
      "title" : "Nanoparticle size Is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis",
      "author" : [ "S Tenzer" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Tenzer,? \\Q2011\\E",
      "shortCiteRegEx" : "Tenzer",
      "year" : 2011
    }, {
      "title" : "Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology",
      "author" : [ "S Tenzer" ],
      "venue" : "Nat. Nanotechnol",
      "citeRegEx" : "Tenzer,? \\Q2013\\E",
      "shortCiteRegEx" : "Tenzer",
      "year" : 2013
    }, {
      "title" : "Multifunctional, stimuli-sensitive nanoparticulate systems for drug",
      "author" : [ "V.P. Torchilin" ],
      "venue" : "delivery. Nat. Rev. Drug Discov",
      "citeRegEx" : "Torchilin,? \\Q2014\\E",
      "shortCiteRegEx" : "Torchilin",
      "year" : 2014
    }, {
      "title" : "Interaction of dermatologically relevant nanoparticles with skin cells and skin",
      "author" : [ "A Vogt" ],
      "venue" : "Beilstein J. Nanotechnol",
      "citeRegEx" : "Vogt,? \\Q2014\\E",
      "shortCiteRegEx" : "Vogt",
      "year" : 2014
    }, {
      "title" : "Effect of absorbed proteins on the wettability of hydrophilic and hydrophobic solids",
      "author" : [ "L. Vroman" ],
      "venue" : "Nature",
      "citeRegEx" : "Vroman,? \\Q1962\\E",
      "shortCiteRegEx" : "Vroman",
      "year" : 1962
    }, {
      "title" : "What the cell “sees” in bionanoscience",
      "author" : [ "D Walczyk" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "Walczyk,? \\Q2010\\E",
      "shortCiteRegEx" : "Walczyk",
      "year" : 2010
    }, {
      "title" : "Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment",
      "author" : [ "C.D. Walkey", "W.C. Chan" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "Walkey and Chan,? \\Q2012\\E",
      "shortCiteRegEx" : "Walkey and Chan",
      "year" : 2012
    }, {
      "title" : "Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles",
      "author" : [ "Walkey", "C.D" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Walkey and C.D,? \\Q2014\\E",
      "shortCiteRegEx" : "Walkey and C.D",
      "year" : 2014
    }, {
      "title" : "The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes",
      "author" : [ "F Wang" ],
      "venue" : "Nanomedicine",
      "citeRegEx" : "Wang,? \\Q2013\\E",
      "shortCiteRegEx" : "Wang",
      "year" : 2013
    }, {
      "title" : "Interview: nanomedicine: past, present and future",
      "author" : [ "T.J. Webster" ],
      "venue" : "Nanomedicine",
      "citeRegEx" : "Webster,? \\Q2013\\E",
      "shortCiteRegEx" : "Webster",
      "year" : 2013
    }, {
      "title" : "Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses",
      "author" : [ "F Wu" ],
      "venue" : "Mol. Pharm",
      "citeRegEx" : "Wu,? \\Q2009\\E",
      "shortCiteRegEx" : "Wu",
      "year" : 2009
    }, {
      "title" : "Polyethylene glycol modified FGF21 engineered to maximize potency and minimize vacuole formation",
      "author" : [ "J Xu" ],
      "venue" : "Bioconjug. Chem",
      "citeRegEx" : "Xu,? \\Q2013\\E",
      "shortCiteRegEx" : "Xu",
      "year" : 2013
    }, {
      "title" : "Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines",
      "author" : [ "Y Yan" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Yan,? \\Q2013\\E",
      "shortCiteRegEx" : "Yan",
      "year" : 2013
    }, {
      "title" : "Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy",
      "author" : [ "Yang", "H.W" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Yang and H.W,? \\Q2012\\E",
      "shortCiteRegEx" : "Yang and H.W",
      "year" : 2012
    }, {
      "title" : "Bio-inspired, bioengineered and biomimetic drug delivery carriers",
      "author" : [ "Yoo", "J.W" ],
      "venue" : "Nat. Rev. Drug Discov",
      "citeRegEx" : "Yoo and J.W,? \\Q2011\\E",
      "shortCiteRegEx" : "Yoo and J.W",
      "year" : 2011
    }, {
      "title" : "Discussion about several potential drawbacks of PEGylated therapeutic proteins",
      "author" : [ "F. Zhang", "M.R. Liu", "H.T. Wan" ],
      "venue" : "Biol. Pharm. Bull",
      "citeRegEx" : "Zhang et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2014
    }, {
      "title" : "Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size",
      "author" : [ "H Zhang" ],
      "venue" : "Proteomics",
      "citeRegEx" : "Zhang,? \\Q2011\\E",
      "shortCiteRegEx" : "Zhang",
      "year" : 2011
    }, {
      "title" : "pH-responsive polymeric micelles based on poly(2-ethyl-2oxazoline)-poly(d,l-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor",
      "author" : [ "Y Zhao" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "Zhao,? \\Q2015\\E",
      "shortCiteRegEx" : "Zhao",
      "year" : 2015
    } ],
    "referenceMentions" : [ {
      "referenceID" : 31,
      "context" : "The applications of engineered nanomaterials (ENMs) are not only increasing in technical products but also more and more in biotechnology and biomedicine (Docter et al., 2015a; Reese, 2013; Webster, 2013; Docter et al., 2015b; Setyawati et al., 2015).",
      "startOffset" : 154,
      "endOffset" : 250
    }, {
      "referenceID" : 50,
      "context" : "The applications of engineered nanomaterials (ENMs) are not only increasing in technical products but also more and more in biotechnology and biomedicine (Docter et al., 2015a; Reese, 2013; Webster, 2013; Docter et al., 2015b; Setyawati et al., 2015).",
      "startOffset" : 154,
      "endOffset" : 250
    }, {
      "referenceID" : 31,
      "context" : "Thus, the ‘marriage’ of nanotechnology with biomedicine defines one of the most exciting and cross-disciplinary developments over the last decade (Reese, 2013; Webster, 2013).",
      "startOffset" : 146,
      "endOffset" : 174
    }, {
      "referenceID" : 50,
      "context" : "Thus, the ‘marriage’ of nanotechnology with biomedicine defines one of the most exciting and cross-disciplinary developments over the last decade (Reese, 2013; Webster, 2013).",
      "startOffset" : 146,
      "endOffset" : 174
    }, {
      "referenceID" : 47,
      "context" : "human ormurine, plasma or serum) to the nanoparticle dispersion are critical aspects (Docter et al., 2015b; Walkey and Chan, 2012).",
      "startOffset" : 85,
      "endOffset" : 130
    }, {
      "referenceID" : 8,
      "context" : ", 2009); ii) minimize side effects due to a non-specific body distribution of the drug and to the high amount of drug commonly used (Ferrari, 2005), and iii) selectively deliver the payload to the affected area, thereby increasing its tissue accumulation (Bertrand et al.",
      "startOffset" : 132,
      "endOffset" : 147
    }, {
      "referenceID" : 3,
      "context" : "While the first-generation nanocarriers, such as micelles, PEGylated liposomes, and polymeric NPs, fully address the first two points by increasing the pharmacokinetics and tolerability of nano-formulate drugs (Riehemann et al., 2009; Dobrovolskaia and McNeil, 2015), the second-generation nanocarriers take advantages from active targeting strategies to tissue-specific delivery (Yang et al.",
      "startOffset" : 210,
      "endOffset" : 266
    }, {
      "referenceID" : 2,
      "context" : "As several receptors on the cell surface are over-expressed in diseases such as cancer (Danhier et al., 2010), these approaches are based on the functionalization of the carrier surface with active molecules,",
      "startOffset" : 87,
      "endOffset" : 109
    }, {
      "referenceID" : 43,
      "context" : "ligands for cell membrane receptors and monoclonal antibodies (Torchilin, 2014).",
      "startOffset" : 62,
      "endOffset" : 79
    }, {
      "referenceID" : 10,
      "context" : "It is well accepted from cell-culture studies that almost all mammalian cells are, in principle, capable to incorporate NPs to some extent, due to a variety of unspecific uptake mechanisms (Hillaireu and Couvreur, 2009).",
      "startOffset" : 189,
      "endOffset" : 219
    }, {
      "referenceID" : 35,
      "context" : ", 2015), accumulation, biodegradation and clearance of NPs (Saptarshi et al., 2013).",
      "startOffset" : 59,
      "endOffset" : 83
    }, {
      "referenceID" : 7,
      "context" : "The immune system is expected to react to NPs, and thus, a better understanding of nano-immuno interactions is critical for the safe application of engineered NPs in medicine (Farrera and Fadeel, 2015).",
      "startOffset" : 175,
      "endOffset" : 201
    }, {
      "referenceID" : 56,
      "context" : "However, despite of all the advantages of PEG, several factors can hinder the application of PEGylated drug carriers, for example the formation of toxic peroxides as a degradation product of PEG or the accumulation of PEG in organs by vacuolization (Zhang et al., 2014; Xu et al., 2013).",
      "startOffset" : 249,
      "endOffset" : 286
    }, {
      "referenceID" : 27,
      "context" : "In nature, the low-density lipoproteins (LDL) present another promising template for designing nano-delivery systems (Ng et al., 2011) consisting of an apolar core surrounded by its own “lipoprotein corona” of phospholipids that may be modified for a targeting and delivering role in nanomedical approaches (Wu et al.",
      "startOffset" : 117,
      "endOffset" : 134
    } ],
    "year" : 2015,
    "abstractText" : "Article history: Received 11 September 2015 Revised 5 November 2015 Accepted 16 November 2015 Available online xxxx Besides thewide use of engineerednanomaterials (ENM) in technical products, their application spectrum inbiotechnology and biomedicine is steadily increasing. In complex physiological environments the physico-chemical properties and the behavior of nanoparticles (NPs) are challenging to characterize. Biomolecules rapidly adsorb to the nanomaterial, leading to the formation of the protein/biomolecule corona, which critically affects the nanomaterials' (patho)biological and technical identities. This formation can trigger an immune response and affect nanoparticles' toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the (protein)corona-nanoparticle interaction and discuss how the corona modulates both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers. © 2015 Elsevier Inc. All rights reserved.",
    "creator" : "Elsevier"
  }
}